IsoRay Appoints Thomas LaVoy as CEO to Take Office on February 15

RICHLAND, Wash., Jan. 14, 2016 -- (Healthcare Sales & Marketing Network) -- IsoRay Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head... Devices, Oncology, PersonnelIsoRay, brachytherapy, radiotherapy

Source: HSMN NewsFeed - January 14, 2016 Category: Pharmaceuticals Source Type: news